Herold, N., Kutzner, J., Bulli, L., & Schaller, T. (2017). Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies. Nature medicine, 23(2), . https://doi.org/10.1038/nm.4265
Chicago Style (17th ed.) CitationHerold, Nikolas, Juliane Kutzner, Lorenzo Bulli, and Torsten Schaller. "Targeting SAMHD1 with the Vpx Protein to Improve Cytarabine Therapy for Hematological Malignancies." Nature Medicine 23, no. 2 (2017). https://doi.org/10.1038/nm.4265.
MLA (9th ed.) CitationHerold, Nikolas, et al. "Targeting SAMHD1 with the Vpx Protein to Improve Cytarabine Therapy for Hematological Malignancies." Nature Medicine, vol. 23, no. 2, 2017, https://doi.org/10.1038/nm.4265.
Warning: These citations may not always be 100% accurate.